BioPharma APAC - Leading Source of Biopharmaceutical Intelligence in Asia Pacific

Contract Services Contract Manufacturing

Porton Advanced and Eureka Therapeutics Partner to Advance Next-Gen T-Cell Therapies

Porton Advanced, a leading contract development and manufacturing organization (CDMO) specializing in advanced therapy medicinal products (ATMPs), is pleas...

March 20, 2025 | News

Celonic Integrates Merck’s Breez™ Micro-Bioreactor to Advance mAb Development

Celonic Group, a Swiss-Based Quality contract development and manufacturing organization (CDMO), has announced that it is integrating Merck’s Breez&t...

March 13, 2025 | News

Vetter to Double Cool Storage Capacity by 2028 with €150M Investment

Cool storage volume to be doubled by 2028 Third expansion stage of Vetter’s Center for Visual Inspection and Logistics State-of-the art, fully au...

March 11, 2025 | News

WuXi Biologics Introduces EffiX™ a High-Yield E. coli Expression Platform for Recombinant Proteins and Plasmid DNA Production

EffiX™ is designed to meet the industry's demand for a high-yield, stable, and non-lysogenic E. coli expression system. ...

March 04, 2025 | News

Chime Biologics and Mabgeek Advance MG-K10 to U.S. Phase III Trials for Atopic Dermatitis and Asthma

Chime Biologics, a leading global CDMO that enables its partners' success in biologics, announced its continued collaboration with Mabgeek ...

February 24, 2025 | News

Eleva and 3PBIOVIAN Forge Strategic Alliance to Advance Clinical-Grade Biologics Production

3PBIOVIAN provides production capacity for clinical-grade material for current and future development programs including Eleva’s proprietary Factor...

February 05, 2025 | News

Spectra and XLPT Rebrand as Elevaris Medical Devices, Advancing Precision Manufacturing

Spectra Medical Devices (Spectra) and XL Precision Technologies (XLPT) announced today their newly combined brand presence as Elevaris Medical Devices, a w...

January 30, 2025 | News

Samsung Biologics Eyes Growth in 2025 with New Plant, ADC Services, and Sustainability Investments

Recorded Q4'24 consolidated revenue of KRW 1.26 trillion Recorded FY'24 consolidated revenue of KRW 4.55 trillion Poised for further growth w...

January 23, 2025 | News

Lyndra Partners with Thermo Fisher to Drive Phase 3 Trials and Commercial Manufacturing of Long-Acting Oral Therapies

Leveraging its Accelerator™ Drug Development, 360° CDMO and CMO solutions, Thermo Fisher will provide clinical research services for Lyndra...

January 16, 2025 | News

Vetter Introduces Next-Gen V-OVS® Closure System: Integrating Customer Insights for Enhanced Performance

New version integrates valuable real-world learnings and customer feedback The latest version of Vetter’s proprietary closure system, V-OVS®&n...

January 15, 2025 | News

BioCina and NovaCina Merge to Establish Global Powerhouse in Biopharmaceutical and Small Molecule Manufacturing

Global Contract Development and Manufacturing Organizations (CDMOs) BioCina and NovaCina announced a strategic merger that will create a powerful brand in ...

January 14, 2025 | News

Samsung Biologics and LigaChem Biosciences Partner to Advance ADC Therapies with New Dedicated Facility

Samsung Biologics to offer ADC services at new dedicated facility Extended collaboration reflects successful partnership and expertise Samsung Biolog...

January 09, 2025 | News

WuXi Biologics Partners with Candid Therapeutics in $925M Deal to Advance Trispecific T-Cell Engagers

WuXi Biologics ("WuXi Bio") (2269. HK), a leading global Contract Research, Development, and Manufacturing Organization (CRDMO), announced an agreemen...

January 07, 2025 | News

WuXi Biologics to Sell $500M Irish Vaccine Facility to Merck & Co. Amid U.S. Legislative Pressures

WuXi Biologics has announced plans to sell its vaccine manufacturing facility in Dundalk, Ireland, to Merck & Co. for approximately $500 million. This ...

January 06, 2025 | News

Stay Connected